Shared insight on the current treatment landscape for myeloproliferative neoplasms (MPNs), including novel therapies for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).
EP. 1: A Background on Myeloproliferative Neoplasms
Experts Rami Komrokji, MD, and Ruben Mesa, MD, define myeloproliferative neoplasms (MPNs) and explain differences between essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).
EP. 2: How Are Myeloproliferative Neoplasms Diagnosed?
Key opinion leaders highlight different testing and workup methods involved in making an accurate diagnosis of myeloproliferative neoplasms.
EP. 3: Overview on the Management of Essential Thrombocythemia and Polycythemia Vera
Centering their discussion on cornerstone therapies, expert hematologist-oncologists consider the treatment paradigms of essential thrombocythemia and polycythemia vera.
EP. 4: Overview of Treatment Options for Myelofibrosis
Switching their focus to myelofibrosis, Rami Komrokji, MD, and Ruben Mesa, MD, consider mainstay treatment options in this setting.
EP. 5: Healthcare Team Members Involved in Treating Myeloproliferative Neoplasms
Comprehensive insight on the various healthcare team members a hematologist-oncologist may work with to optimize care of myeloproliferative neoplasms.
EP. 6: Adverse Events Tied to Treatment for Myeloproliferative Neoplasms
Expert perspectives on the possible adverse events patients may encounter while receiving treatment for myeloproliferative neoplasms.
EP. 7: Novel Treatment Strategies in Essential Thrombocythemia and Polycythemia Vera
Focusing on clinical trials and novel therapies, Rami Komrokji, MD, and Ruben Mesa, MD, share their hope for the future management of essential thrombocythemia and polycythemia vera.
EP. 8: Myelofibrosis: Novel Treatment Strategies and Combination Therapies
Comprehensive discussion on the management of myelofibrosis, covering both monotherapy and combination therapy strategies.
EP. 9: MF Progression to Acute Myeloid Leukemia and Subsequent Treatment
Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.
2 Clarke Drive Cranbury, NJ 08512